Severe Nodular Acne

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cipher Pharmaceuticals
Cipher PharmaceuticalsON - Mississauga
1 program
1
CIP-IsotretinoinPhase 31 trial
Active Trials
NCT00975143CompletedEst. May 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cipher PharmaceuticalsCIP-Isotretinoin

Clinical Trials (1)

NCT00975143Cipher PharmaceuticalsCIP-Isotretinoin

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Start: Sep 2009Est. completion: May 2011
Phase 3Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space